Table 1.
General Characteristics and Blood Chemistry of Subjects.
| Parameters | Placebo | Ferulic Acid | P1 | P2 | ||
|---|---|---|---|---|---|---|
| Baseline | 6 Week | Baseline | 6 Week | |||
| Age (years) | 45.88 ± 7.84 | - | 48.71 ± 7.55 | - | 0.209 | |
| Sex (n) | ||||||
| -Male | 3 | 3 | 3 | 3 | ||
| -Female | 21 | 21 | 21 | 21 | ||
| Weight (kg) | 65.32 ± 19.25 | 65.24 ± 19.53 | 64.37 ± 15.87 | 64.34 ± 16.06 | 0.852 | 0.863 |
| Body Mass Index (kg/m2) | 26.58 ± 6.20 | 26.54 ± 6.29 | 25.88 ± 5.31 | 25.86 ± 5.36 | 0.676 | 0.689 |
| Waist circumference (cm) | 88.80 ± 11.48 | 88.52 ± 11.43 | 87.99 ± 10.54 | 87.72 ± 11.03 | 0.800 | 0.805 |
| Body fat (%) | 33.84 ± 5.89 | 33.43 ± 6.31 | 34.95 ± 3.97 | 34.32 ± 4.18 | 0.445 | 0.567 |
| Blood pressure (mm Hg) | ||||||
| -Systolic | 123.04 ± 19.06 | 117.83 ± 14.25 | 123.17 ± 17.3 | 123.08 ± 15.36 | 0.981 | 0.226 |
| -Diastolic | 80.38 ± 11.29 | 77.08 ± 12.53 | 80.29 ± 10.16 | 77.04 ± 10.09 | 0.979 | 0.990 |
| Glucose (mg/dL) | 88.58 ± 7.76 | 85.63 ± 7.73 | 84.96 ± 8.01 | 82.79 ± 8.72 | 0.118 | 0.240 |
| ALT (U/L) | 18.67 ± 4.80 | 18.08 ± 4.47 | 18.42 ± 5.39 | 18.67 ± 5.50 | 0.866 | 0.689 |
| AST (U/L) | 22.00 ± 6.65 | 21.67 ± 6.81 | 21.46 ± 5.29 | 20.17 ± 4.99 | 0.756 | 0.389 |
| Creatinine (mg/dL) | 0.77 ± 0.11 | 0.78 ± 0.12 | 0.75 ± 0.13 | 0.74 ± 0.13 | 0.491 | 0.330 |
Values are means ± SD. P1 = Comparison of mean between the two groups at baseline; P2 = Comparison of mean between the two groups at six weeks; Significant differences at p < 0.05. ALT, alanine aminotransferase; AST, aspartate transaminase.